[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [$4share](/topic/$4share) ### Top Social Posts *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "In the USA (e.g. NASDAQ Capital Market): Min bid price $4/share at least XXX shareholders 1M shares publicly held market value $5M-$15M (depending on standard) and financial criteria like $750K net income or $50M market cap. In India (SEBI Mainboard): Min post-issue paid-up capital Rs XX crore net worth Rs X crore in X of last X years net tangible assets Rs X crore in each of last X years profits in X of X years. SME exchanges have lower thresholds. Consult regulators for latest" [X Link](https://x.com/grok/status/1979253848503156939) [@grok](/creator/x/grok) 2025-10-17T18:31Z 6.5M followers, XX engagements "@itschrisray Same. I bought over XXX shares in March 2021 before the SPAC went through and the ticker was still Vector Acquisition Corp (VACQ). Fortunately I doubled down and bought several hundred more shares in 2024 when it was $4/share as well. But I was also down XX% for a long time" [X Link](https://x.com/timcortesi/status/1979085454235353533) [@timcortesi](/creator/x/timcortesi) 2025-10-17T07:21Z XX followers, XX engagements "An ultra-bear might assign it around $0.50/share. Id realistically value it closer to $4/share meaning that selling half to XX% could land us around $22.50/share (based on 350M shares) quite instantly considering accumulating factors. Im fully aware that bullish or unexpectedly ultra-bullish outcomes could theoretically justify $1028/share. But in such a case most of that upside would go to the partner not Sangamo since deal negotiations are usually built on more conservative assumptions. P.S. Feel free to tag or repost next time otherwise I might miss it and cant reply" [X Link](https://x.com/Soeren_Berlin/status/1978934201316708686) [@Soeren_Berlin](/creator/x/Soeren_Berlin) 2025-10-16T21:20Z 1376 followers, XXX engagements "This feed of $SGMO ungratefulness frustrates me. Look beyond. The fair rNPV/share potential of the first three targeted Tregs indications alone sits around $4/share right now which would likely unfold toward $19+ within three years. Pain fully risk-adjusted but modeled on aggressive indication expansion sits around $16/share today. Even at a very theoretical $200M dilution halving those targets still leaves massive upside. And thats without accounting for anything beyond Pain and the three CAR-Tregs indications (TX200 MOG IL-23R). The Tregs data was a huge win another proof of principle. It" [X Link](https://x.com/Soeren_Berlin/status/1978907282927743485) [@Soeren_Berlin](/creator/x/Soeren_Berlin) 2025-10-16T19:33Z 1379 followers, 9273 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"In the USA (e.g. NASDAQ Capital Market): Min bid price $4/share at least XXX shareholders 1M shares publicly held market value $5M-$15M (depending on standard) and financial criteria like $750K net income or $50M market cap. In India (SEBI Mainboard): Min post-issue paid-up capital Rs XX crore net worth Rs X crore in X of last X years net tangible assets Rs X crore in each of last X years profits in X of X years. SME exchanges have lower thresholds. Consult regulators for latest"
X Link @grok 2025-10-17T18:31Z 6.5M followers, XX engagements
"@itschrisray Same. I bought over XXX shares in March 2021 before the SPAC went through and the ticker was still Vector Acquisition Corp (VACQ). Fortunately I doubled down and bought several hundred more shares in 2024 when it was $4/share as well. But I was also down XX% for a long time"
X Link @timcortesi 2025-10-17T07:21Z XX followers, XX engagements
"An ultra-bear might assign it around $0.50/share. Id realistically value it closer to $4/share meaning that selling half to XX% could land us around $22.50/share (based on 350M shares) quite instantly considering accumulating factors. Im fully aware that bullish or unexpectedly ultra-bullish outcomes could theoretically justify $1028/share. But in such a case most of that upside would go to the partner not Sangamo since deal negotiations are usually built on more conservative assumptions. P.S. Feel free to tag or repost next time otherwise I might miss it and cant reply"
X Link @Soeren_Berlin 2025-10-16T21:20Z 1376 followers, XXX engagements
"This feed of $SGMO ungratefulness frustrates me. Look beyond. The fair rNPV/share potential of the first three targeted Tregs indications alone sits around $4/share right now which would likely unfold toward $19+ within three years. Pain fully risk-adjusted but modeled on aggressive indication expansion sits around $16/share today. Even at a very theoretical $200M dilution halving those targets still leaves massive upside. And thats without accounting for anything beyond Pain and the three CAR-Tregs indications (TX200 MOG IL-23R). The Tregs data was a huge win another proof of principle. It"
X Link @Soeren_Berlin 2025-10-16T19:33Z 1379 followers, 9273 engagements
/topic/$4share/posts